Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iguratimod Combined With Tofacitinib in RF Positive/Negative RA
NCT06146972Phase 4Recruiting
- Start
- Jun 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iguratimod in rheumatoid arthritis (RA). Started Jun 2021; status: recruiting.
02
Drugs
iguratimod
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT06146972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06146972.